Miglustat

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Link	Tested on	Impact factor	Notes	Publication date
Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2 Preprint	VERO E6 cell cultures			May/18/2020

Link	Publication date
alpha-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19.	Apr/01/2022
Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2	Jul/20/2021